title: (99m)Tc-MIBI Whole Body Scan: A Potentially Useful Technique for Evaluating Metabolic Bone Disease.
abstract: Metabolic bone disease due to hyperparathyroidism is characterized by increased bone resorption and new bone formation. (99m)Tc- hexakis-2-methoxyisobutylisonitrile ((99m)Tc MIBI) accumulation is controlled by metabolic function and cell viability. To investigate, for the first time, the potential of whole body (99m)Tc MIBI scan for detecting, visually and with the aid of quantitative analysis, bony changes associated with hyperparathyroidism. Eighty-six patients with hyperparathyroidism, referred routinely for parathyroid localization, were included in this case-control prospective study. Each patient was injected with 20-25 mCi of (99m)Tc MIBI. Routine anterior cervico-thoracic images were obtained for parathyroid localization. Two extra whole body images were acquired and assessed visually and by drawing regions of interest over the mandible, sternum, femur, humeri, spine, and the soft tissue adjacent to the bone. The ratios of bone to soft tissue were calculated and compared to ratios drawn in a control group routinely referred for cardiac imaging and injected with (99m)Tc MIBI, after confirming the absence of any bone disease. The visual interpretation of the scans showed 48 patients to have increased bone uptake. Quantitative assessment showed significant difference between the mean ratios of the case and control groups. The Kruskal-Wallis test showed significant agreement between visual and quantitative ratios drawn from delayed right and left femora and left humerus images (P < 0.05). (99m)Tc MIBI whole body imaging is a potentially useful technique for assessing metabolic bone disease associated with hyperparathyroidism. Quantitative analysis helped in confirming the visual findings.
authors: Department of Nuclear Medicine, Faculty of Medicine, Kuwait University and Mubarak Al-Kabeer Hospital, Kuwait.
authors: A M
authors: AM
authors: Al-Shammari
authors: A H
authors: AH
authors: Elgazzar
authors: Rasha A
authors: RA
authors: Ashkanani
keywords: 99mTc- hexakis-2-methoxyisobutylisonitrile; Hyperparathyroidism; metabolic bone disease
references: Clin Nucl Med. 1997 Nov;22(11):798-9
references: 9363401
references: J Nucl Med. 1990 Apr;31(4):464-72
references: 2324822
references: J Nucl Med. 1997 Apr;38(4):501-6
references: 9098190
references: Clin Nucl Med. 2001 Jan;26(1):65-7
references: 11139061
references: Clin Nucl Med. 1996 Mar;21(3):192-6
references: 8846562
references: Clin Nucl Med. 1998 Feb;23(2):83-5
references: 9481494
references: J Nucl Med. 1992 Mar;33(3):319-24
references: 1531501
references: J Nucl Med. 1995 May;36(5):811-3
references: 7738654
references: J Nucl Med. 2001 Jan;42(1):33-7
references: 11197977
references: Eur J Nucl Med. 1984;9(9):419-25
references: 6437823
references: Clin Nucl Med. 1997 Oct;22(10):691-4
references: 9343725
references: J Clin Endocrinol Metab. 2001 Nov;86(11):5138-41
references: 11701666
references: Clin Nucl Med. 2003 Sep;28(9):775-7
references: 12973007
references: Semin Nucl Med. 1997 Jul;27(3):291-305
references: 9224668
references: Clin Nucl Med. 1996 Feb;21(2):118-21
references: 8697680
references: J Nucl Med. 1987 Apr;28(4):458-61
references: 3572533